Home6919 • TPE
add
Caliway Biopharmaceuticals Co Ltd
Previous close
$161.00
Day range
$157.00 - $164.00
Year range
$54.10 - $277.00
Market cap
244.27B TWD
Avg Volume
10.55M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
In the news
Financials
Income Statement
Revenue
Net income
| (TWD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 13.42M | -42.32% |
Operating expense | 210.81M | 24.63% |
Net income | -7.73M | 94.38% |
Net profit margin | -57.62 | 90.26% |
Earnings per share | -0.01 | 89.90% |
EBITDA | -195.81M | -32.61% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.52B | -32.78% |
Total assets | 9.46B | -3.53% |
Total liabilities | 78.32M | 11.51% |
Total equity | 9.38B | — |
Shares outstanding | 1.55B | — |
Price to book | 26.61 | — |
Return on assets | -5.31% | — |
Return on capital | -5.36% | — |
Cash Flow
Net change in cash
| (TWD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.73M | 94.38% |
Cash from operations | -68.22M | 42.90% |
Cash from investing | -4.46B | -23,338.31% |
Cash from financing | -21.40M | -100.33% |
Net change in cash | -4.57B | -171.70% |
Free cash flow | -196.01M | -70.93% |
About
Founded
2012
Website
